Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review

被引:4
|
作者
Nies, Jasper F. F. [1 ]
Schneider, Udo [2 ]
Krusche, Martin [3 ]
机构
[1] Univ Med Ctr Cologne, Internal Med 2, Cologne, Germany
[2] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Dept Nephrol Rheumatol & Endocrinol, Hamburg, Germany
关键词
adult-onset Still's disease (AOSD); interstitial lung disease; pulmonary arterial hypertension; IL-6; blocking; IL-1; PULMONARY ARTERIAL-HYPERTENSION; JUVENILE IDIOPATHIC ARTHRITIS; CYTOKINE; PATIENT; CELLS; MANIFESTATIONS; EPIDEMIOLOGY; PATHOGENESIS; SAFETY; IL-1;
D O I
10.3389/fmed.2022.989777
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adult-onset Still's disease (AOSD) is a polygenic systemic autoinflammatory disease which is associated with increased morbidity and mortality. Pulmonary involvement is a rare, but serious complication of AOSD. As in AOSD, IL-1b, IL-18, and IL-6 dominate the molecular pathogenesis, which mediate a type 1 and type 3 inflammatory signature of the adaptive immune system. This is evidenced by the success of IL-1- and IL-6 inhibition in the management of AOSD. However, anaphylactic reactions to treatment with IL-1- or IL-6-inhibitors is currently being discussed as a potential trigger for lung involvement inf AOSD, while genetic risk factors have also been identified. Clinically, pulmonary involvement in AOSD can manifest in many different forms. Parenchymal inflammation with peripheral consolidations is the most frequent form while PAH is less common, but often very difficult to manage. This mini-review provides an overview of the pathophysiology as well as the clinical presentation and the diagnostic features of pulmonary involvement in AOSD.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Therapeutic responses and prognosis in adult-onset Still's disease
    Kim, Hyoun-Ah
    Sung, Jun-Mo
    Suh, Chang-Hee
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (05) : 1291 - 1298
  • [32] Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review
    Cota-Arce, Julian M.
    Cota, Jonhatan
    De Leon-Nava, Marco A.
    Hernandez-Caceres, Alexia
    Moncayo-Salazar, Leopoldo, I
    Valle-Alvarado, Fidel
    Cordero-Moreno, Vera L.
    Bonfil-Solis, Karen L.
    Bichara-Figueroa, Jesus E.
    Hernandez-Hernandez, Jose
    Villela, Luis
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (06) : 1282 - 1290
  • [33] Clinical characteristics and treatment of elderly onset adult-onset Still's disease
    Kishida, Dai
    Ichikawa, Takanori
    Takamatsu, Ryota
    Nomura, Shun
    Matsuda, Masayuki
    Ishii, Wataru
    Nagai, Tatsuo
    Suzuki, Sadahiro
    Ueno, Ken-ichi
    Tachibana, Naoki
    Shimojima, Yasuhiro
    Sekijima, Yoshiki
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [34] Indices and ferritin level that predict organ involvement in adult-onset Still's disease
    Kaya, Mehmet Nur
    Kilic, Ozlem
    Gunes, Ezgi Cimen
    Tecer, Duygu
    Yilmaz, Sedat
    BIOMARKERS IN MEDICINE, 2024, 18 (20) : 899 - 906
  • [35] Biologic treatments for adult-onset Still's disease
    Al-Homood, Ibrahim A.
    RHEUMATOLOGY, 2014, 53 (01) : 32 - 38
  • [36] Complex presentation of adult-onset Still's disease
    Zafran, Muhammad
    Wassef, Nancy
    BMJ CASE REPORTS, 2019, 12 (04)
  • [37] New Markers for Adult-Onset Still's Disease
    Mitrovic, Stephane
    Fautrel, Bruno
    JOINT BONE SPINE, 2018, 85 (03) : 285 - 293
  • [38] Use of methotrexate in adult-onset Still's disease
    Manger, B.
    Rech, J.
    Schett, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S168 - S171
  • [39] Biological treatment in adult-onset Still's disease
    Pouchot, Jacques
    Arlet, Jean-Benoit
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2012, 26 (04): : 477 - 487
  • [40] Adult-onset Still's disease: Advances in the treatment
    Castaneda, Santos
    Blanco, Ricardo
    Gonzalez-Gay, Miguel A.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (02): : 222 - 238